Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 9
July 2024
Volume 65, Issue 9
Open Access
ARVO Imaging in the Eye Conference Abstract  |   July 2024
Comparison between the Nidek MP-3 and CenterVue MAIA microperimetry devices in healthy and diseased eyes
Author Affiliations & Notes
  • Muhammad Usman Jamil
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Anna Marmalidou
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Haleema Siddiqui
    Tufts University School of Medicine, Boston, Massachusetts, United States
  • Li-Yin Lee
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Hiroyuki Takahashi
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Antonio Yaghy
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Stephanie Kaiser
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • A Yasin Alibhai
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Peter Y Zhao
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Shilpa Desai
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Andre J. Witkin
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Michelle Liang
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Christopher Robinson
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Caroline R. Baumal
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Nadia K Waheed
    Ophthalmology, New England Eye Center, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Muhammad Usman Jamil, None; Anna Marmalidou, None; Haleema Siddiqui, None; Li-Yin Lee, Beacon therapeutics (C); Hiroyuki Takahashi, None; Antonio Yaghy, Beacon therapeutics (C); Stephanie Kaiser, Ocuphire (C); A Alibhai, Beacon therapeutics (C), Boston Imaging and Reading Center (E); Peter Zhao, Beacon therapeutics (C), Boston Imaging and Reading Center (C), Olix Pharmaceuticals (C); Shilpa Desai, None; Andre Witkin, Apellis (F), Genetech (F); Michelle Liang, Beacon therapeutics (C), Genentech (R); Christopher Robinson, None; Caroline Baumal, Apellis (E), EyePoint Pharma (C), Genentech (C), Ocuphire (C), Ophthea (C), Ora (C); Nadia Waheed, Beacon therapeutics (E), Complement therapeutics (C), Hubble (C), Iolyx Pharmaceuticals (C), Nidek (F), NIDEK (C), Ocudyne (I), Olix Pharma (C), Saliogen (C), Syncona (C), Topcon (F), Topcon (C), Zeiss (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2024, Vol.65, PB00117. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Muhammad Usman Jamil, Anna Marmalidou, Haleema Siddiqui, Li-Yin Lee, Hiroyuki Takahashi, Antonio Yaghy, Stephanie Kaiser, A Yasin Alibhai, Peter Y Zhao, Shilpa Desai, Andre J. Witkin, Michelle Liang, Christopher Robinson, Caroline R. Baumal, Nadia K Waheed; Comparison between the Nidek MP-3 and CenterVue MAIA microperimetry devices in healthy and diseased eyes. Invest. Ophthalmol. Vis. Sci. 2024;65(9):PB00117.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare and correlate mean sensitivities obtained with the Nidek MP-3 and CenterVue MAIA microperimetry devices.

Methods : A prospective comparative cross-sectional study was conducted by enrolling subjects with normal eyes as well as diseased eyes of patients having Diabetes (DM) without Diabetic Retinopathy (DR), DR (varying in severity from mild non-proliferative DR to proliferative DR), and non-exudative Age-related Macular Degeneration (AMD). Patients underwent testing on both the Nidek MP-3 and the MAIA microperimetry devices, alternating the testing sequence using a pre-programmed 10-2 macular grid with 68 stimuli and other consistent parameters. To understand the relationship between the two devices, Bland-Altman repeatability analysis was conducted. Conversion formulas from MP-3 to MAIA were identified using both a shift method and a simple regression method. The coefficient of Repeatability (CoR) between MAIA and converted values from MP-3 were calculated to quantify absolute reliability and define the requirement for a clinically significant change that is beyond natural variability.

Results : 111 eyes from 80 subjects were enrolled with a mean age of 57.2 + 20.3 years. This cohort included 43 healthy eyes, 14 eyes with DM without DR, 32 eyes with DR, and 22 eyes with AMD. Two conversion formulas were developed. Using the shift and regression methods, MAIA_shift and MAIA_Reg values were derived, respectively. On Bland-Altman analysis, the majority of measured mean sensitivities for the healthy, DR, and AMD groups fell between the upper and lower limits of agreement. The healthy group data points closely follow the regression line, indicating a strong positive correlation between the measurements. In contrast, diseased eyes displayed variability, deviating from the regression line. The CoRs were 2.78 for MAIA vs. MAIA_shift and 2.71 for MAIA vs. MAIA_reg. The comparisons between each patient group and the healthy subjects remained consistent across all parameters (MAIA, MAIA converted from MP-3 using the shift method, MAIA converted from MP-3 using the simple regression method, and MP-3).

Conclusions : Retinal sensitivity measurements were consistently higher for MAIA than MP-3. Despite this, there was a stable correlation between the two devices. Limitations included a lack of randomization.

This abstract was presented at the 2024 ARVO Imaging in the Eye Conference, held in Seattle, WA, May 4, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×